Related references
Note: Only part of the references are listed.Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization
Bohua Li et al.
CANCER RESEARCH (2013)
A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity
Wenlong Tan et al.
MABS (2013)
A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein
Yong-Qiang Deng et al.
PLOS ONE (2011)
Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity
Federico Narvaez et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo
Jianxin Dai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin
Geng Kou et al.
CANCER LETTERS (2010)
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification
Scott J. Balsitis et al.
PLOS PATHOGENS (2010)
On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes
Ravikumar Rajamanonmani et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III
Kiyohiko Matsui et al.
VIROLOGY (2009)
A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
Bruce S. Thompson et al.
PLOS PATHOGENS (2009)
VEGF receptor protein-tyrosine kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins
Shee-Mei Lok et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
The flavivirus precursor membrane-envelope protein complex: Structure and maturation
Long Li et al.
SCIENCE (2008)
Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin
Chengbin Wu et al.
NATURE BIOTECHNOLOGY (2007)
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus
Gregory D. Gromowski et al.
VIROLOGY (2007)
Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters
John D. Morrey et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Structural basis of West Nile virus neutralization by a therapeutic antibody
GE Nybakken et al.
NATURE (2005)
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
T Oliphant et al.
NATURE MEDICINE (2005)
A structural perspective of the Flavivirus life cycle
S Mukhopadhyay et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization
K Jessie et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Structure of the dengue virus envelope protein after membrane fusion
Y Modis et al.
NATURE (2004)
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
JS Mackenzie et al.
NATURE MEDICINE (2004)
Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice
MJ Engle et al.
JOURNAL OF VIROLOGY (2003)
Dengue hemorrhagic fever in infants: Research opportunities ignored
SB Halstead et al.
EMERGING INFECTIOUS DISEASES (2002)
Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody
A Nowakowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Bispecific antibodies targeting cancer cells
M Peipp et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion
RJ Kuhn et al.
CELL (2002)
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells
WD Crill et al.
JOURNAL OF VIROLOGY (2001)
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
DW Vaughn et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
